News Headlines

Alnylam and Collaborators Publish new Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene
31 August 2010
New Research shows silencing of alpha-synuclein in the Substantia Nigra of non-human primates with an RNAi therapeutic.

Marina Biotech Announces Issuance of a U.S. Patent Broadly Covering its Amphoteric Liposomal siRNA Delivery Technology
25 August 2010
Patent further strengthens Marina Biotech's RNA delivery intellectual property portfolio.

The Porcine microRNAome is Revealed
23 August 2010
Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies.

Quark and Novartis Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002
20 August 2010
Novartis gains an exclusive worldwide license to develop and commercialize the p53 temporary inhibitor siRNA drug for $10 million.

Bioo Scientific Chooses Eureka Genomics as its Next-Generation Sequencing Provider
19 August 2010
Bioo Scientific chose Eureka Genomics based on their extensive sequencing experience, quick turnaround times and strong bioinformatics support.

Scientists Uncover Achilles Heel of Chronic Inflammatory Pain
19 August 2010
BBSRC funded discovery could lead to a brand new class of drugs to treat chronic pain caused by inflammatory conditions.

In NIH-Funded Study, Researchers Uncover Early Step in the Cascade of Brain Events Leading up to Addiction
17 August 2010
Findings represent additional clues to help predict vulnerability to drug abuse.

Parent Project Muscular Dystrophy Awards $600K to Nationwide Children's Hospital for Gene Therapy Study
16 August 2010
Dr. Jerry Mendell to lead follistatin gene therapy for Duchenne muscular dystrophy.

Sigma® Life Science and Switchgear Genomics to Co-Develop Simplified MicroRNA Target Validation System
13 August 2010
Combining SwitchGear Genomics’ expertise with Sigma’s lentiviral technology, new target reporter system is expected to simplify miRNA target validation.

Sigma® Life Science and Switchgear Genomics to Co-Develop Simplified Novel MicroRNA Target Validation System
10 August 2010
SwitchGear Genomics and Sigma’s lentiviral technology combined to simplify miRNA target validation, enabling researchers to investigate gene regulation.

Horizon Awarded €300,000 Grant Under EUFP7 Program
09 August 2010
The Company will develop human isogenic disease models to predict the activity of potential therapeutic agents for the program.

GenomeQuest and SGI Announce Whole-Genome Analysis Architecture
09 August 2010
Researcher can now have direct access to whole-genome processing previously found only inside genome centers.

Biosearch Technologies Signs Exclusive License for Single Molecule FISH Technologies from UMDNJ
06 August 2010
Biosearch owns the exclusive rights to manufacture, catalogue and sell validated RNA FISH probes, assays and kits.

  
Select Biosciences Ltd